ZA200710853B - Immunogenic composition - Google Patents

Immunogenic composition

Info

Publication number
ZA200710853B
ZA200710853B ZA200710853A ZA200710853A ZA200710853B ZA 200710853 B ZA200710853 B ZA 200710853B ZA 200710853 A ZA200710853 A ZA 200710853A ZA 200710853 A ZA200710853 A ZA 200710853A ZA 200710853 B ZA200710853 B ZA 200710853B
Authority
ZA
South Africa
Prior art keywords
immunogenic composition
immunogenic
composition
Prior art date
Application number
ZA200710853A
Other languages
English (en)
Inventor
Biemans Ralph Leon
Capiau Carine
Duvivier Pierre
Dominique Boutriau
Philippe Denoel
Jan Poolman
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of ZA200710853B publication Critical patent/ZA200710853B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA200710853A 2005-06-27 2007-12-13 Immunogenic composition ZA200710853B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0513069.5A GB0513069D0 (en) 2005-06-27 2005-06-27 Immunogenic composition

Publications (1)

Publication Number Publication Date
ZA200710853B true ZA200710853B (en) 2009-04-29

Family

ID=34856207

Family Applications (3)

Application Number Title Priority Date Filing Date
ZA200710853A ZA200710853B (en) 2005-06-27 2007-12-13 Immunogenic composition
ZA200710909A ZA200710909B (en) 2005-06-27 2007-12-14 Immunogenic composition
ZA200711074A ZA200711074B (en) 2005-06-27 2007-12-18 Process for manufacturing vaccines

Family Applications After (2)

Application Number Title Priority Date Filing Date
ZA200710909A ZA200710909B (en) 2005-06-27 2007-12-14 Immunogenic composition
ZA200711074A ZA200711074B (en) 2005-06-27 2007-12-18 Process for manufacturing vaccines

Country Status (8)

Country Link
CN (4) CN101208101B (2)
BE (1) BE2021C560I2 (2)
ES (1) ES2367918T5 (2)
FR (1) FR12C0060I2 (2)
GB (1) GB0513069D0 (2)
NO (2) NO2021022I1 (2)
UA (1) UA97233C2 (2)
ZA (3) ZA200710853B (2)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2809349T3 (da) * 2012-01-30 2019-02-18 Serum Institute Of India Pvt Ltd Immunogen sammensætning
SI2885007T1 (sl) * 2012-08-16 2018-12-31 Pfizer Inc. Postopki in kompozicije glikokonjugacij
KR102906912B1 (ko) * 2016-09-02 2026-01-05 사노피 파스퇴르 인크 네이세리아 메닌기티디스 백신
JP7165468B2 (ja) * 2016-11-25 2022-11-04 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ｎＯＭＶ－抗原コンジュゲート及びその使用
CN109879967A (zh) * 2017-12-15 2019-06-14 苏州和锐生物科技有限公司 一种乙酰氨基葡萄糖偶联物的制备方法及应用
CN110251667A (zh) * 2018-05-11 2019-09-20 武汉博沃生物科技有限公司 一种免疫组合制剂及其制备方法和应用
US12533418B2 (en) * 2019-11-22 2026-01-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
CN115819616B (zh) * 2021-07-28 2025-04-11 江苏瑞科生物技术股份有限公司 一种基因重组vzv融合蛋白及其制备方法和应用
CN115721709A (zh) * 2021-08-27 2023-03-03 康希诺生物股份公司 一种肺炎球菌结合疫苗制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180815A (en) * 1988-04-13 1993-01-19 Fuji Photo Film Co., Ltd. Modified protein for carrying hapten
HU227893B1 (en) * 2000-06-29 2012-05-29 Glaxosmithkline Biolog Sa Vaccine compositions
EP1372707A1 (en) * 2001-04-06 2004-01-02 Institut Pasteur Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae 0139 bound to tetanus toxoid
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
CN1401328A (zh) * 2002-10-18 2003-03-12 北京绿竹生物技术有限责任公司 流行性脑脊髓膜炎多糖－蛋白结合疫苗
ES2461350T3 (es) * 2003-01-30 2014-05-19 Novartis Ag Vacunas inyectables contra múltiples serogrupos de meningococos

Also Published As

Publication number Publication date
UA97233C2 (uk) 2012-01-25
FR12C0060I1 (2) 2012-12-14
CN101222935A (zh) 2008-07-16
BE2021C560I2 (2) 2026-02-02
FR12C0060I2 (fr) 2017-01-06
GB0513069D0 (en) 2005-08-03
CN101208103B (zh) 2013-04-24
ZA200710909B (en) 2009-04-29
ES2367918T5 (es) 2014-11-21
NO2021022I1 (no) 2021-05-25
CN101208101A (zh) 2008-06-25
CN101247827A (zh) 2008-08-20
CN101247827B (zh) 2013-07-17
CN101208101B (zh) 2013-01-02
ES2367918T3 (es) 2011-11-10
NO2025018I1 (no) 2025-04-08
CN101208103A (zh) 2008-06-25
CN101222935B (zh) 2015-07-29
ZA200711074B (en) 2009-07-29

Similar Documents

Publication Publication Date Title
AP2436A (en) Immunogenic composition
IL181825A0 (en) Immunogenic composition
IL227934A0 (en) Immunogenic preparation
IL186828A0 (en) Vaccine composition
GB0526038D0 (en) Immunogenic composition
ZA200710909B (en) Immunogenic composition
EP1847249A4 (en) hair dye
GB0421079D0 (en) Immunogenic composition
GB0606416D0 (en) Immunogenic composition
ZA200710854B (en) Immunogenic composition
GB0515556D0 (en) Immunogenic composition
GB0526041D0 (en) Immunogenic composition
GB0526040D0 (en) Immunogenic composition
GB0503143D0 (en) Immunogenic composition
GB0524204D0 (en) Immunogenic composition
GB0502569D0 (en) Vaccine composition
GB0421078D0 (en) Immunogenic composition
GB0421081D0 (en) Immunogenic composition
GB0421082D0 (en) Immunogenic composition
GB0606417D0 (en) Immunogenic composition
ZA200702752B (en) Immunogenic compositions
HK1116408A (en) Immunogenic composition
HK1116412A (en) Immunogenic composition
GB0509563D0 (en) Composition
GB0515907D0 (en) Composition